In the current issue of Circulation, Mehta and colleagues compared 1-year saphenous vein graft failure (defined as ≥75% angiographic stenosis or occlusion) and 5-year clinical events (composite of ...

while performing angioplasty and stenting procedures in coronary saphenous vein bypass grafts and carotid arteries; the diameter of the vessel at the site of filter loop placement should be between ...

In such a situation, let us know from the doctor in simple language when bypass surgery is done on the patient and whether the heart can be kept safe only with angioplasty. How much can the risk ...

while performing angioplasty and stenting procedures in coronary saphenous vein bypass grafts and carotid arteries; the diameter of the vessel at the site of filter loop placement should be between ...

Systems MarketThe global endoscopic vessel harvesting systems market is entering a promising growth phase, anticipated to expand steadily from USD 577.1 million in 2025 to USD 949.0 million by 2035, ...

Heart bypass surgery is a new beginning for patients, significantly enhancing longevity and quality of life. It is performed when critical blockages are present and may involve angioplasty with ...

Learn more about whether LeMaitre Vascular, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether LeMaitre Vascular, Inc. or PROCEPT BioRobotics Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A non-bioabsorbable stent intended to be implanted in a coronary artery or saphenous vein graft of the heart to maintain luminal patency and ... A device intended to facilitate/regulate the delivery ...

A rendering of the Elana bypass system. [Image courtesy of AMT Medical] AMT Medical announced today that it raised $25 million in a Series B financing round to support its Elana heart bypass system.